Evidence map›Paper›PMID 22692069›Full record

ArticleChinese journal of cancer2012

Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.

Zhi-Ming Li, Ying-Jie Zhu, Yi Xia, Jia-Jia Huang, Wen-Qi Jiang

Abstract read
In one paragraph

Article in Chinese journal of cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Primary hepatic lymphoma: dilemmas in diagnostic approach and therapeutic management.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2014
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Zhi-Ming LiDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, Guangdong, People's Republic of China.
Ying-Jie Zhu
Yi Xia
Jia-Jia Huang
Wen-Qi Jiang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differences between Hodgkin's lymphoma (HL) patients in China and Western countries are known to exist, but data on Chinese patients with HL are limited. It is not clear whether there are clinical and histological differences in patients with HL involving different extranodal sites. This is the first study to analyze Chinese patients with HL involving different extranodal sites. We selected 22 HL patients with extranodal involvement from more than 250 previously untreated HL patients. Most patients were young males, and 20 of the 22 patients had stage IV disease. The major pathologic types were nodular sclerosis classical HL (NSCHL) and mixed cellularity classical HL(MCCHL). At diagnosis, the most commonly involved extranodal sites were the liver and lung, followed by the bones. There was no significant association between the international prognostic score(IPS) and survival in patients with different extranodal sites. Our data showed the overall survival (OS) and disease-free survival (DFS) rates of low-risk group (IPS = 0-2) were relatively higher than those of high-risk group (IPS ≥ 3), but the IPS did not show predictive power for survival. Although HL with extranodal involvement is rare, it should be considered as a unique form of HL.

Indexed as

AdolescentAdultAgedAntineoplastic Combined Chemotherapy ProtocolsBleomycinBone NeoplasmsCyclophosphamideDacarbazineDisease-Free SurvivalDoxorubicinEtoposideFemaleFollow-Up StudiesHodgkin DiseaseHumansLiver NeoplasmsBleomycinCyclophosphamideDacarbazineDoxorubicinEtoposidePrednisoneProcarbazineVinblastineVincristine

Identifiers

PMID22692069
PMCPMC3777495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.